Preprint Data Descriptor Version 1 Preserved in Portico This version is not peer-reviewed

CoviRx: A User-Friendly Interface for Systematic Down-Selection of Repurposed Drug Candidates for COVID-19

Version 1 : Received: 20 September 2022 / Approved: 21 September 2022 / Online: 21 September 2022 (10:14:11 CEST)

How to cite: Jain, H.A.; Agarwal, V.; Bansal, C.; Kumar, A.; Faheem, F.; Mohammed, M.; Murugesan, S.; Simpson, M.M.; Karpe, A.V.; Chandra, R.; MacRaild, C.A.; Styles, I.K.; Peterson, A.L.; Cooper, M.A.; Kirkpatrick, C.M.; Shah, R.M.; Palombo, E.A.; Trevaskis, N.L.; Creek, D.J.; Vasan, S.S. CoviRx: A User-Friendly Interface for Systematic Down-Selection of Repurposed Drug Candidates for COVID-19. Preprints 2022, 2022090323 (doi: 10.20944/preprints202209.0323.v1). Jain, H.A.; Agarwal, V.; Bansal, C.; Kumar, A.; Faheem, F.; Mohammed, M.; Murugesan, S.; Simpson, M.M.; Karpe, A.V.; Chandra, R.; MacRaild, C.A.; Styles, I.K.; Peterson, A.L.; Cooper, M.A.; Kirkpatrick, C.M.; Shah, R.M.; Palombo, E.A.; Trevaskis, N.L.; Creek, D.J.; Vasan, S.S. CoviRx: A User-Friendly Interface for Systematic Down-Selection of Repurposed Drug Candidates for COVID-19. Preprints 2022, 2022090323 (doi: 10.20944/preprints202209.0323.v1).

Abstract

Although various vaccines are now commercially available, they have not been able to stop the spread of COVID-19 infection completely. An excellent strategy to quickly get safe, effective, and affordable COVID-19 treatment is to repurpose drugs that are already approved for other diseases as adjuvants along with the ongoing vaccine regime. The process of developing an accurate and standardized drug repurposing dataset requires a considerable level of resources and expertise due to the commercial availability of an extensive array of drugs that could be potentially used to address the SARS-CoV-2 infection. To address this bottleneck, we created the CoviRx platform. CoviRx is a user-friendly interface that provides access to the data, which is manually curated for COVID-19 drug repurposing data. Through CoviRx, the data curated has been made open-source to help advance drug repurposing research. CoviRx also encourages users to submit their findings after thoroughly validating the data, followed by merging it by enforcing uniformity and integ-rity-preserving constraints. This article discusses the various features of CoviRx and its design principles. CoviRx has been designed so that its functionality is independent of the data it dis-plays. Thus, in the future, this platform can be extended to include any other disease X beyond COVID-19. CoviRx can be accessed at www.covirx.org.

Keywords

COVID-19; Open-source dataset; Drug Repurposing; Database system; Web application devel-opment; software development; Drug fingerprints; Bulk upload

Subject

MATHEMATICS & COMPUTER SCIENCE, Information Technology & Data Management

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.

Leave a public comment
Send a private comment to the author(s)
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.

We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.